Focus on the BIG picture.
Tuesday, Oct 20, 2026
Outside the box.
Food and Drug Administration Launches Streamlined Regulatory Framework for Rare Disease Drug Development
Federal health regulators have established a new holistic initiative designed to accelerate the development, testing, and approval of specialized pharmaceuticals targeting rare diseases, aiming to reduce the often prohibitive costs of medical breakthroughs.